A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies

NCT06208878 · clinicaltrials.gov ↗

ENROLLING_BY_INVITATION

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Hematologic Malignancy
Solid Malignancy

Interventions

OTHER: Non Interventional

Sponsor

CRISPR Therapeutics AG